Article
Multi-omics biomarkers aid prostate cancer prognostication
2022-09-22
Abstract excerpt
Effective biomarkers and diagnostic tools are urgently needed in clinical settings for improved management of prostate cancer patients, especially to reduce over-treatment of indolent tumors and for early identification of aggressive disease. Gene expression signatures are currently the “gold standard” to provide guide clinical decision, however their clinical utility and interpretability is questionable. Multi-mo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3f9a644c-a4a8-5bda-81e7-cde809fb4e86
- DOI
- 10.1101/2022.09.20.508244
